Radiotherapy with two parallel opposed lateral fields will be administered in fractions of 1.8 Gy/day, given 5 days per week for 25 days. The total dose of radiation will be 45 Gy. TS-1 (80-120mg/day
Sponsors
Graduate School of Medicine, Osaka Univesity
Conditions
Advanced or recurrent rectal canceradvanced and recurrent rectal Cancer
Phase 1
Phase I/II study of TS-1 / Oxaliplatin / Cetuximab / Radiation for KRAS wild type locally advanced and recurrent rectal cancer.
RecruitingJPRN-UMIN000006304
Start: 2011-10-01Target: 31Updated: 2026-06-29
Phase I/II study of TS-1 / Oxaliplatin / Radiation for KRAS mutation type locally advanced and recurrent rectal cancer.
RecruitingJPRN-UMIN000006305
Start: 2011-10-01Target: 31Updated: 2026-06-29